|
Volumn 148, Issue 3, 2008, Pages 197-213
|
Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
25 HYDROXYVITAMIN D;
ALENDRONIC ACID;
ALFACALCIDOL;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
COLECALCIFEROL;
ERGOCALCIFEROL;
ESTROGEN;
ETIDRONIC ACID;
GESTAGEN;
GLUCOCORTICOID;
IBANDRONIC ACID;
PAMIDRONIC ACID;
PARATHYROID HORMONE[1-34];
PLACEBO;
RALOXIFENE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
VITAMIN D;
VITAMIN D DERIVATIVE;
ZOLEDRONIC ACID;
ANDROGEN;
BONE DENSITY CONSERVATION AGENT;
TESTOSTERONE;
ACUTE CORONARY SYNDROME;
ADVERSE OUTCOME;
BONE DENSITY;
BONE NECROSIS;
BREAST CANCER;
CANCER RISK;
CEREBROVASCULAR ACCIDENT;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COLON CANCER;
COMPARATIVE STUDY;
DATA BASE;
DIGESTIVE SYSTEM PERFORATION;
DIGESTIVE SYSTEM ULCER;
ESOPHAGUS IRRITATION;
ESOPHAGUS ULCER;
FRACTURE;
FRACTURE REDUCTION;
FRAGILITY FRACTURE;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL HEMORRHAGE;
GASTROINTESTINAL REFLUX;
GASTROINTESTINAL SYMPTOM;
HEART ATRIUM FIBRILLATION;
HEART DEATH;
HEART PALPITATION;
HEARTBURN;
HIP FRACTURE;
HUMAN;
LUNG CANCER;
LUNG EMBOLISM;
MEDLINE;
METHODOLOGY;
NAUSEA;
OSTEOPOROSIS;
PRIORITY JOURNAL;
REVIEW;
SEX DIFFERENCE;
SIDE EFFECT;
STROKE;
SYSTEMATIC REVIEW;
TACHYCARDIA;
THERAPY EFFECT;
THORAX PAIN;
THROMBOEMBOLISM;
VASODILATATION;
VERTEBRA FRACTURE;
VOMITING;
ARTICLE;
ESTROGEN THERAPY;
FEMALE;
MALE;
META ANALYSIS;
RISK FACTOR;
ANDROGENS;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
CALCIUM;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
FRACTURES, BONE;
HUMANS;
MALE;
OSTEOPOROSIS;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TESTOSTERONE;
VITAMIN D;
|
EID: 39349086278
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-3-200802050-00198 Document Type: Review |
Times cited : (441)
|
References (164)
|